D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Travere Therapeutics
TVTX
$2.23B
| $12.3M | 0.01% |
475,401
+128,060
| +37% | +$3.3M |
|
852
Dutch Bros
BROS
$8.44B
| $12.2M | 0.01% |
221,008
-51,939
| -19% | -$2.87M |
|
853
Shutterstock
SSTK
$750M
| $12.2M | 0.01% |
131,074
+44,039
| +51% | +$4.1M |
|
854
Itron
ITRI
$5.51B
| $12.2M | 0.01% |
231,251
+194,941
| +537% | +$10.3M |
|
|
FBC
855
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $12.2M | 0.01% |
286,764
-111,767
| -28% | -$4.74M |
|
856
Industrial Select Sector SPDR Fund
XLI
$23.5B
| $12.2M | 0.01% |
+118,000
| New | +$12.2M |
|
857
Vulcan Materials
VMC
$39.9B
| $12.1M | 0.01% |
66,118
-52,029
| -44% | -$9.56M |
|
|
SVFA
858
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
| $12.1M | 0.01% |
1,237,210
+212,751
| +21% | +$2.09M |
|
859
Diageo
DEO
$57.6B
| $12.1M | 0.01% |
59,569
+42,272
| +244% | +$8.59M |
|
860
Wyndham Hotels & Resorts
WH
$6.75B
| $12.1M | 0.01% |
142,521
-58,309
| -29% | -$4.94M |
|
861
Nuburu, Inc.
BURU
$15.2M
| $12.1M | 0.01% |
30,477
+8,747
| +40% | +$3.46M |
|
862
Olaplex Holdings
OLPX
$961M
| $12.1M | 0.01% |
771,372
+500,344
| +185% | +$7.82M |
|
863
Extra Space Storage
EXR
$31.5B
| $12M | 0.01% |
58,576
+918
| +2% | +$189K |
|
864
Editas Medicine
EDIT
$244M
| $12M | 0.01% |
632,911
+269,778
| +74% | +$5.13M |
|
865
Generac Holdings
GNRC
$11B
| $12M | 0.01% |
40,489
+8,316
| +26% | +$2.47M |
|
866
Alaska Air
ALK
$7.36B
| $12M | 0.01% |
207,141
-548,317
| -73% | -$31.8M |
|
867
Graphic Packaging
GPK
$6.24B
| $12M | 0.01% |
599,319
+178,113
| +42% | +$3.57M |
|
868
FTI Consulting
FCN
$5.4B
| $12M | 0.01% |
76,211
-37,820
| -33% | -$5.95M |
|
|
WARR
869
DELISTED
Warrior Technologies Acquisition Company
WARR
| $12M | 0.01% |
1,211,476
-24,588
| -2% | -$243K |
|
|
PCPC
870
DELISTED
Periphas Capital Partnering Corporation
PCPC
| $11.9M | 0.01% |
485,550
-11,800
| -2% | -$289K |
|
|
TCN
871
DELISTED
Tricon Residential Inc.
TCN
| $11.9M | 0.01% |
749,200
+69,100
| +10% | +$1.1M |
|
872
CareDx
CDNA
$720M
| $11.9M | 0.01% |
321,483
-147,684
| -31% | -$5.46M |
|
873
Bank of Montreal
BMO
$90.8B
| $11.9M | 0.01% |
100,969
+66,969
| +197% | +$7.88M |
|
874
Theravance Biopharma
TBPH
$690M
| $11.8M | 0.01% |
1,239,042
+362,579
| +41% | +$3.47M |
|
875
Commault Systems
CVLT
$8.04B
| $11.8M | 0.01% |
178,406
-48,243
| -21% | -$3.2M |
|